| Primary |
| Gastrooesophageal Reflux Disease |
15.4% |
| Gastritis |
12.8% |
| Hypertension |
7.7% |
| Hypothyroidism |
7.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
7.7% |
| Abdominal Pain Upper |
5.1% |
| Dyspepsia |
5.1% |
| Oesophagitis |
5.1% |
| Panniculitis |
5.1% |
| Arrhythmia |
2.6% |
| Arterial Bypass Operation |
2.6% |
| Diarrhoea |
2.6% |
| Duodenal Ulcer |
2.6% |
| Duodenal Ulcer Haemorrhage |
2.6% |
| Gastritis Erosive |
2.6% |
| Gastrointestinal Disorder |
2.6% |
| Gouty Arthritis |
2.6% |
| Hiatus Hernia |
2.6% |
| Hyperlipidaemia |
2.6% |
| Hypersensitivity |
2.6% |
|
| Hypothyroidism |
11.5% |
| Proteinuria |
11.5% |
| Diarrhoea |
7.7% |
| Tachycardia |
7.7% |
| Aortic Aneurysm |
3.8% |
| Gastric Polyps |
3.8% |
| Gingival Bleeding |
3.8% |
| Gouty Arthritis |
3.8% |
| Gynaecomastia |
3.8% |
| Heart Rate Increased |
3.8% |
| Hiatus Hernia |
3.8% |
| Hypertension |
3.8% |
| Lip Oedema |
3.8% |
| Oesophageal Candidiasis |
3.8% |
| Off Label Use |
3.8% |
| Oral Disorder |
3.8% |
| Overdose |
3.8% |
| Peripheral Sensory Neuropathy |
3.8% |
| Phlebitis |
3.8% |
| Rash Vesicular |
3.8% |
|
| Secondary |
| Hypertension |
19.6% |
| Product Used For Unknown Indication |
13.7% |
| Cerebrovascular Accident |
7.8% |
| Chronic Obstructive Pulmonary Disease |
7.8% |
| Gastrooesophageal Reflux Disease |
5.9% |
| Arrhythmia |
3.9% |
| Diarrhoea |
3.9% |
| Gastritis |
3.9% |
| Gastritis Erosive |
3.9% |
| Hiatus Hernia |
3.9% |
| Nausea |
3.9% |
| Small Intestine Carcinoma |
3.9% |
| Vomiting |
3.9% |
| Abdominal Pain Upper |
2.0% |
| Delusional Disorder, Unspecified Type |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Dyspepsia |
2.0% |
| Gouty Arthritis |
2.0% |
| Mental Disorder |
2.0% |
| Pneumonia |
2.0% |
|
| Walking Disability |
26.7% |
| Gastric Polyps |
13.3% |
| Rash Vesicular |
13.3% |
| Aortic Aneurysm |
6.7% |
| Gouty Arthritis |
6.7% |
| Gynaecomastia |
6.7% |
| Platelet Count Decreased |
6.7% |
| Psychotic Disorder |
6.7% |
| Thrombocytopenia |
6.7% |
| Vision Blurred |
6.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.2% |
| Hypertension |
8.5% |
| Prophylaxis |
8.3% |
| Rheumatoid Arthritis |
5.9% |
| Drug Use For Unknown Indication |
4.9% |
| Acute Coronary Syndrome |
4.2% |
| Haemorrhoidal Haemorrhage |
3.7% |
| Anaemia |
3.2% |
| Atrial Fibrillation |
3.2% |
| Crohn's Disease |
3.2% |
| Colitis Ulcerative |
3.1% |
| Haemodialysis |
2.4% |
| Multiple Sclerosis |
2.0% |
| Renal Transplant |
2.0% |
| Renal Failure Chronic |
1.9% |
| Anxiety Disorder |
1.5% |
| Glioblastoma Multiforme |
1.5% |
| Cardiac Disorder |
1.4% |
| Hepatitis C |
1.4% |
| Myocardial Ischaemia |
1.4% |
|
| Vomiting |
13.6% |
| Rhabdomyolysis |
9.1% |
| Thrombocytopenia |
9.1% |
| Atrial Fibrillation |
6.1% |
| Transient Ischaemic Attack |
6.1% |
| Weight Decreased |
6.1% |
| Crohn's Disease |
4.5% |
| Oedema Peripheral |
4.5% |
| Pyrexia |
4.5% |
| Vitiligo |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Coronary Artery Stenosis |
3.0% |
| Demyelinating Polyneuropathy |
3.0% |
| Gastrointestinal Haemorrhage |
3.0% |
| Glomerulonephritis Membranous |
3.0% |
| Haematochezia |
3.0% |
| Haemoglobin Decreased |
3.0% |
| Hip Fracture |
3.0% |
| Hypoaesthesia Oral |
3.0% |
| Ischaemic Stroke |
3.0% |
|
| Interacting |
| Gastrooesophageal Reflux Disease |
50.0% |
| Hypothyroidism |
50.0% |
|
|
